Menu Close

Artikel-artikel mengenai B.1.1.7 variant

Menampilkan semua artikel

The AstraZeneca vaccine was 70 per cent effective against symptomatic COVID-19 infection in a large multinational study, and recently reported 76 per cent overall efficacy against symptomatic COVID-19 in another large study done primarily in the United States. THE CANADIAN PRESS/John Woods

AstraZeneca COVID-19 vaccine FAQ: Why do the age recommendations keep changing? Does it cause VIPIT blood clots? Is it effective against variants?

With changing recommendations about AstraZeneca's COVID-19 vaccine making headlines, many people have questions about its use.
A COVID-19 patient in an ICU unit in a hospital in Capetown, South Africa, in December 2020. A variant emerged in South Africa that has since spread to other parts of the world. Other new variants could emerge elsewhere. Rodger Bosch/AFP via Getty Images

How worried should you be about coronavirus variants? A virologist explains his concerns

As the US vaccinates millions more people each day, the novel coronavirus works to survive. It does this by mutating. So far, several variants are worrisome. A virologist explains what they are.

Kontributor teratas

Lebih banyak